If your vial or pen has been frozen, do not use it
While this sounds encouraging, we must recognize this was not a controlled trial there was no placebo group, and the patients (and doctors) knew they were receiving the peptide
We would like to thank the group of Manola Comar at the Burlo Garofolo childrens Hospital in Trieste, Italy, for providing us access to the Bio-Plex 200 multiplexing technology
Only half of the infectious particles were present in the cells treated with WL-1 at 10 M concentration with a 50% antiviral activity at this dose, which suggested that WL-1 reduces the viable viral load
I look at sourcing, consistency between batches, and whether the product has been properly handled from start to finish
The results reported a 6.0%, 6.8%, 9.1%, 9.7%, and 10.8% decrease in body weight for the groups receiving cagrilintide in doses of 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg, respectively [1]